Igor Bakman

Chief Technology & Product Officer at Vivira Health Lab

Igor Bakman has a diverse work experience spanning multiple industries. Igor is currently serving as the Chief Technology Officer at Vivira Health Lab since August 2021. Prior to that, they worked at Caresyntax as the Director of Software Engineering and Development Team Lead from December 2018 to July 2021. At Caresyntax, they led cross-functional teams in the healthcare sector and designed and implemented software solutions for operating room efficiency.

Before joining Caresyntax, Igor Bakman worked at CG Solutions as the Chief Software Architect from August 2017 to December 2018. During this time, they focused on designing cloud-based architecture, migrating towards big data, and improving product quality. Additionally, they held the roles of Java Team Leader and Senior Software Engineer at CG Solutions.

Igor Bakman started their career as an R&D Software Engineer at ForeScout Technologies from August 2013 to August 2014. Igor then worked as a Software Engineer at Continuity Software from December 2010 to August 2013.

Prior to entering the software industry, Igor Bakman gained valuable experience as a Student Software Engineer at Eltel Technologistics LTD. from December 2007 to April 2010. Igor also served in the IDF - Israel Defence Forces as a Telecommunications Technician from February 2003 to January 2006, where they were responsible for building and maintaining computer and communication networks for a large number of users.

Igor Bakman obtained a BSc in Tele-Communication Engineering from Ben-Gurion University of the Negev, where they studied from 2007 to 2011. In addition to their degree, they have also completed two certifications: "The Gradle Masterclass" from Udemy in January 2019 and "Elasticsearch 6 and Elastic Stack - In Depth and Hands On!" from Udemy in May 2018.

Links

Previous companies

Caresyntax logo

Timeline

  • Chief Technology & Product Officer

    May 1, 2023 - present

  • Chief Technology Officer

    August, 2021